Alta Partners Management Company, L.P. holds a concentrated book of 2 stocks worth $127.3M as of Q2 2026 (disclosed Jul 22, 2026, a ~45-day 13F lag). This quarter they opened Allakos Inc. Their largest long position is Tyra Biosciences Inc at 96% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/2054419/holdings"
Use Arkolith to show Alta Partners Management Company, L.P.'s latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Other tracked managers holding the same core names as Alta Partners Management Company, L.P.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| FMR LLC | 2 / 2 | $315.3M |
| BlackRock, Inc. | 2 / 2 | $246.2M |
| JANUS HENDERSON GROUP PLC | 2 / 2 | $149.4M |
| FARALLON CAPITAL MANAGEMENT LLC | 2 / 2 | $137.3M |
| VANGUARD GROUP INC | 2 / 2 | $117.0M |
| STATE STREET CORP | 2 / 2 | $110.6M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2 / 2 | $92.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2 / 2 | $91.3M |
Ranked by how many of Alta Partners Management Company, L.P.'s top 2 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 22, 2026 | 2 | $127.3M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 21, 2026 | 2 | $151.0M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 13, 2026 | 2 | $103.6M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 7, 2025 | 2 | $60.0M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 2 | $41.6M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 12, 2025 | 3 | $41.8M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 5, 2025 | 3 | $63.4M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.